Effects of Eplivanserin, a non-sedative agent, on driving an cognitive/psychomotor performance a randomizes placebo-and active-controlled trial in insomnia patients with difficulties maintaining sleep.

Luthringer R, Floch A, Delfolie A, Nicolas O, Brunet A, Pinquier J (presented by Staner L).

APSS (Seatle, USA), June 6-11, 2009 (Poster)

06/06/2009

---